Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

Bacteria-Based Live Vehicle for In Vivo Bioluminescence Imaging

Bacteria-Based Live Vehicle for <i>In Vivo</i> Bioluminescence Imaging

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Bioluminescent Bacterial Imaging in Vivo

Genetically engineered probiotics for an optical imaging-guided tumor photothermal therapy/immunotherapy

In vivo bioluminescence imaging of natural bacteria within deep tissues via ATP-binding cassette sugar transporter

In Vivo Optical Imaging of Bacterial Infection and Antibiotic Response in Intact Nude Mice

Real-time imaging of tumors using replication-competent light-emitting microorganisms.

Optical Imaging: Bacteria, Viruses, and Mammalian Cells Encoding Light-Emitting Proteins Reveal the Locations of Primary Tumors and Metastases in Animals

Engineering Bioluminescent Bacteria to Boost Photodynamic Therapy and Systemic Anti-Tumor Immunity for Synergistic Cancer Treatment.

Engineering of Bacteria for the Visualization of Targeted Delivery of A Cytolytic Anticancer Agent

Compact Whole-Body Fluorescent Imaging of Nude Mice Bearing Egfp Expressing Tumor

Engineered NIR light-responsive bacteria as anti-tumor agent for targeted and precise cancer therapy

In Vivo Bioluminescence Imaging of Natural Bacteria Via ATP-binding Cassette Sugar Transporter

Advances in the Development of Bacterial Bioluminescence Imaging

Near‐Infrared Nano‐Optogenetic Activation of Cancer Immunotherapy via Engineered Bacteria

Upconversion Optogenetic Engineered Bacteria System for Time-Resolved Imaging Diagnosis and Light-Controlled Cancer Therapy

Cancer-cell killing by engineered Salmonella imaged by multiphoton tomography in live mice.

Development of a Self-Luminescent Living Bioreactor for Enhancing Photodynamic Therapy in Breast Cancer

Visualization of Tumors and Metastases in Live Animals with Bacteria and Vaccinia Virus Encoding Light-Emitting Proteins

<i>Escherichia</i><i>coli</i> Nissle 1917 as a Novel Microrobot for Tumor-Targeted Imaging and Therapy